Ömür Tabak
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Diabetes Treatment and Management
Papers in
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 3
- Surgery 8
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Hafize Uzun (20 shared papers)Füsun Erdenen (9 shared papers)Remise Gelışgen (14 shared papers)Reşat Özaras (8 shared papers)Hayriye Erman (3 shared papers)Hale Aral (3 shared papers)Fehmı Tabak (6 shared papers)Volkan Sözer (4 shared papers)
- Journals
- Clinical and investigative medicine (3 papers)Scientific Reports (2 papers)Biomarkers in Medicine (2 papers)Diabetes Obesity and Metabolism (2 papers)Digestive Diseases and Sciences (2 papers)
- Partner nations
- TürkiyeUnited StatesDenmark
In The Last Decade
Ömür Tabak
40 papers receiving 646 citations
Peers
Comparison fields: 5 of 87
- Clinical Biochemistry 51
- Endocrinology, Diabetes and Metabolism 103
- Hepatology 47
- Epidemiology 124
- Endocrine and Autonomic Systems 23
Countries citing papers authored by Ömür Tabak
This map shows the geographic impact of Ömür Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömür Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömür Tabak more than expected).
Fields of papers citing papers by Ömür Tabak
This network shows the impact of papers produced by Ömür Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömür Tabak. The network helps show where Ömür Tabak may publish in the future.
Co-authors
The 25 scholars most cited alongside Ömür Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 106 | |
| 2 | 2013 | 65 | |
| 3 | 2022 | 55 | |
| 4 | 2019 | 36 | |
| 5 | 2008 | 33 | |
| 6 | 2011 | 26 | |
| 7 | 2017 | 26 | |
| 8 | 2019 | 21 | |
| 9 | The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome. | 2016 | 19 |
| 10 | 2008 | 19 | |
| 11 | Plasma ghrelin, leptin, and orexin-A levels and insulin resistance after laparoscopic gastric band applications in morbidly obese patients. | 2013 | 19 |
| 12 | 2012 | 18 | |
| 13 | Port-related Delftia tsuruhatensis bacteremia in a patient with breast cancer. | 2013 | 18 |
| 14 | 2009 | 17 | |
| 15 | 2010 | 16 | |
| 16 | 2013 | 15 | |
| 17 | 2010 | 14 | |
| 18 | 2009 | 14 | |
| 19 | 2011 | 13 | |
| 20 | 2012 | 13 |
About Ömür Tabak
Ömür Tabak is a scholar working on Epidemiology, Surgery, Physiology, Infectious Diseases and Oncology, having authored 45 papers that have together received 659 indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (4 papers), COVID-19 Clinical Research Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Adipose Tissue and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Diabetes Treatment and Management (2 papers), Cardiovascular Disease and Adiposity (2 papers) and Nutrition and Health in Aging (2 papers). The work is most often cited by research in Clinical Biochemistry (51 citations), Endocrinology, Diabetes and Metabolism (103 citations), Hepatology (47 citations), Epidemiology (124 citations) and Endocrine and Autonomic Systems (23 citations). Ömür Tabak has collaborated with scholars based in Türkiye, United States and Denmark. Frequent co-authors include Hafize Uzun, Füsun Erdenen, Remise Gelışgen, Reşat Özaras, Hayriye Erman, Hale Aral, Fehmı Tabak, Volkan Sözer, Veysel Tahan and Gülcan Güntaş. Their work appears in journals such as Clinical and investigative medicine, Scientific Reports, Biomarkers in Medicine, Diabetes Obesity and Metabolism and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.